Skip to main content

Table 1 Demographic Data of patients in N-acetyl cysteine group and control group

From: The effect of N-acetyl cysteine injection on renal function after coronary artery bypass graft surgery: a randomized double blind clinical trial

Parameter

N-acetyl cysteine group(n = 30)

Control group(n = 30)

P-Value

Sex

 Male n(%)

22(73.4)

24(80)

0.761

 Female n(%)

8(26.6)

6(20)

Age (Year)

65.43 ± 14.850

63.00 ± 10.932

0.178

Weight (Kg)

82.23 ± 14.231

79.80 ± 12.452

0.785

LVEF%

45.67 ± 5.371

48.83 ± 4.086

0.181

Diabetes (n%)

27(90)

23(76.6)

0.381

Smoking (n%)

25(83.3)

20(66.6)

0.326

HTN (n%)

24(80)

27(90)

0.236

HLP (n%)

23(76.6)

24(80)

0.501

Preoperative Hb(g/dl)

12.3 ± 1.6

13.2 ± 2.0

0.001

Duration of surgery (min)

204.67 ± 41.646

211.00 ± 34.476

0.524

CPB Time (min)

44.33 ± 11.198

46.67 ± 9.679

0.391

ACC Time (min)

59.00 ± 14.468

64.83 ± 25.680

0.213

  1. LVEF Left ventricular ejection fraction, HTN Hypertension, HLP, Hyperlipidemia, Hb Hemoglobin, CPB Cardiopulmonary bypass, ACC Aortic cross clamp.
  2. Data are expressed as mean ± SD. The t-test was statistical analysis